[Biomedical researches: for whom? for what? how?]

Area of Science:

• Medical Law
• Clinical Trials Ethics
• Pharmaceutical Regulation

Context:

• The legal framework for clinical research protection was established by the December 20th, 1988 law.
• Clinicians face challenges with novel pharmaceuticals and industry-driven experimental protocols.
• Existing ambiguities in clinical research regulations persist.

Purpose:

• To analyze the protective measures for clinical research participants under the 1988 law.
• To examine the implications of new drugs and experimental protocols for clinicians.
• To identify and address the "grey areas" within current clinical research legislation.

Summary:

• The 1988 law offers protection to individuals participating in clinical research, encompassing both patients and healthy volunteers.
• Expert clinicians are encountering new drugs and experimental designs originating from the pharmaceutical industry.
• The authors aim to clarify existing ambiguities in clinical research law and practice.

Impact:

• Enhanced understanding of participant protection in clinical trials.
• Improved guidance for clinicians navigating new drug development and experimentation.
• Potential for regulatory refinement to address identified "grey areas" in clinical research ethics and law.